R&D
Rooted in distinctive platform technology based on strong medicinal chemistry expertise, LCB is a global biotechnology company dedicated to drug discovery and development
Core Technology
Our Technology
Ligachemisty
Novel drug discovery using "building blocks", namely, drug scaffold with drug-like properties
Successful advancement of drug development pipeline in clinical stage
- Delpazolid (antibiotics for gram-positive pathogens and TB)
- Nokxaban (anticoagulant)
- ADCs (anticancer), particularly the linker platform
Accelerated drug discovery by rapid candidate drug identification
5 to 3 years
5 to 3 years
LCB's Approach
